{"id":16365,"date":"2023-04-24T00:00:00","date_gmt":"2023-04-24T04:00:00","guid":{"rendered":"https:\/\/livingstagenew.wpenginepowered.com\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/"},"modified":"2026-06-25T10:09:19","modified_gmt":"2026-06-25T14:09:19","slug":"livingstone-advises-neoplas-meds-series-b-financing-round","status":"publish","type":"transaction","link":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","title":{"rendered":"Livingstone asesora a neoplas med en su ronda de financiaci\u00f3n de serie B"},"content":{"rendered":"\n<p><strong>El equipo de Healthcare de Livingstone en D\u00fcsseldorf ha seguido con su asesoramiento a <\/strong><a href=\"https:\/\/neoplas-med.eu\/en\/\"><strong>neoplas med GmbH<\/strong><\/a><strong> y su segunda ronda de financiaci\u00f3n. <\/strong><a href=\"https:\/\/niterra.de\/\"><strong>Niterra<\/strong><\/a><strong> (anteriormente NGK Spark Plug Co., LTD) ampl\u00eda su asociaci\u00f3n con la empresa de tecnolog\u00eda m\u00e9dica a trav\u00e9s de una inversi\u00f3n de crecimiento en asociaci\u00f3n con <\/strong><a href=\"https:\/\/www.pegasustechventures.com\/\"><strong>Pegasus Technology Ventures<\/strong><\/a><strong>. El objetivo de la inversi\u00f3n es apoyar la internacionalizaci\u00f3n de neoplas med desde Greifswald, Alemania y avanzar en el desarrollo de nuevos productos y aplicaciones de la tecnolog\u00eda del plasma fr\u00edo.<\/strong><\/p>\n<p>En junio de 2022, Livingstone asesor\u00f3 a neoplas med GmbH en su ronda inicial de financiaci\u00f3n y consigui\u00f3 al grupo tecnol\u00f3gico japon\u00e9s NGK Spark Plug (que opera como Niterra desde abril de 2023) como socio estrat\u00e9gico. Neoplas med ha desarrollado una terapia para el tratamiento de heridas cr\u00f3nicas e infectadas en la que el plasma fr\u00edo se aplica sin contacto, bajo control visual y casi sin dolor. El plasma fr\u00edo del <a href=\"https:\/\/neoplas-med.eu\/en\/product\/\">kINPen<sup>\u00ae<\/sup> MED<\/a> mata g\u00e9rmenes y pat\u00f3genos y estimula la microcirculaci\u00f3n, as\u00ed como la neovascularizaci\u00f3n y la proliferaci\u00f3n celular.<\/p>\n<p>Niterra es un grupo tecnol\u00f3gico japon\u00e9s especializado desde su creaci\u00f3n en buj\u00edas, tecnolog\u00eda de sensores y cer\u00e1mica t\u00e9cnica. Su divisi\u00f3n m\u00e9dica desarrolla tecnolog\u00edas respiratorias, de salud femenina, de atenci\u00f3n domiciliaria y de plasma fr\u00edo. Con un balance de m\u00e1s de 1.000 millones de d\u00f3lares y un fondo de capital riesgo corporativo de 100 millones de d\u00f3lares establecido en asociaci\u00f3n con Pegasus Tech Ventures, invierten globalmente en tecnolog\u00edas punteras, incluyendo dispositivos m\u00e9dicos.<\/p>\n<p><em>\u00abHemos duplicado nuestras ventas en 2022 y agradecemos a nuestro socio estrat\u00e9gico Niterra su confianza y apoyo para impulsar la internacionalizaci\u00f3n y el desarrollo de nuevos canales de distribuci\u00f3n. Estamos orgullosos del s\u00f3lido resultado y nos complace que Niterra siga ampliando su compromiso estrat\u00e9gico. Este es otro hito en nuestros esfuerzos por seguir desarrollando nuestra innovadora tecnolog\u00eda de plasma jet y ponerla a disposici\u00f3n del mayor n\u00famero posible de personas en todo el mundo\u00bb<\/em>, afirma <strong>Ulrike Sailer<\/strong>, CEO de neoplas med GmbH.<\/p>\n<p><em>\u00abLa tecnolog\u00eda de neoplas med y su reconocimiento en la comunidad m\u00e9dica nos atrajeron desde el principio. Dirigida por Ulrike Sailer, la empresa se ha desarrollado muy bien, y estoy muy ilusionado con su potencial de crecimiento\u00bb<\/em>, afirma <strong>Dirk Schapeler<\/strong>, Presidente de Niterra Ventures Company.<\/p>\n<p><a href=\"https:\/\/livingstonepartners.com\/es\/team\/dr-ralf-nowak\/\"><strong>Dr. Ralf Nowak<\/strong><\/a>, Socio de Livingstone en D\u00fcsseldorf comenta: \u00ab<em>Estamos muy satisfechos de acompa\u00f1ar a neoplas med en su camino de start-up a empresa tecnol\u00f3gica din\u00e1mica. Niterra es un socio ideal para neoplas med, apoyando el viaje en curso de la internacionalizaci\u00f3n y la diversificaci\u00f3n de la base de productos, as\u00ed como las \u00e1reas de aplicaci\u00f3n.\u00bb<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>neoplas med y Niterra ampl\u00edan su asociaci\u00f3n estrat\u00e9gica<\/p>\n","protected":false},"featured_media":3863,"template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"client-type":[],"region":[],"sector":[],"service":[],"transaction-type":[],"class_list":["post-16365","transaction","type-transaction","status-publish","has-post-thumbnail","hentry"],"acf":{"team_members":[1773,1801],"date":"20230424","client_type":46,"type":[1034],"region":[396,402,1219],"services":[],"sectors":[843,852],"related_transactions":[16346,16187,16055,15963],"related_testimonials":"","contacts":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Livingstone asesora a neoplas med en su ronda de financiaci\u00f3n de serie B - Livingstone Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Livingstone asesora a neoplas med en su ronda de financiaci\u00f3n de serie B - Livingstone Partners\" \/>\n<meta property=\"og:description\" content=\"neoplas med y Niterra ampl\u00edan su asociaci\u00f3n estrat\u00e9gica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/\" \/>\n<meta property=\"og:site_name\" content=\"Livingstone Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-25T14:09:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png\" \/>\n\t<meta property=\"og:image:width\" content=\"550\" \/>\n\t<meta property=\"og:image:height\" content=\"370\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/\",\"name\":\"Livingstone asesora a neoplas med en su ronda de financiaci\u00f3n de serie B - Livingstone Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/18343c2a.png\",\"datePublished\":\"2023-04-24T04:00:00+00:00\",\"dateModified\":\"2026-06-25T14:09:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#primaryimage\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/18343c2a.png\",\"contentUrl\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/18343c2a.png\",\"width\":550,\"height\":370},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Homepage\",\"item\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions\",\"item\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/transaction\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Livingstone asesora a neoplas med en su ronda de financiaci\u00f3n de serie B\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/\",\"name\":\"Livingstone Partners\",\"description\":\"Deals Done Right.\",\"publisher\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#organization\",\"name\":\"Livingstone Partners\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo_livingstone.svg\",\"contentUrl\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo_livingstone.svg\",\"caption\":\"Livingstone Partners\"},\"image\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Livingstone asesora a neoplas med en su ronda de financiaci\u00f3n de serie B - Livingstone Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","og_locale":"es_ES","og_type":"article","og_title":"Livingstone asesora a neoplas med en su ronda de financiaci\u00f3n de serie B - Livingstone Partners","og_description":"neoplas med y Niterra ampl\u00edan su asociaci\u00f3n estrat\u00e9gica","og_url":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","og_site_name":"Livingstone Partners","article_modified_time":"2026-06-25T14:09:19+00:00","og_image":[{"width":550,"height":370,"url":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","url":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","name":"Livingstone asesora a neoplas med en su ronda de financiaci\u00f3n de serie B - Livingstone Partners","isPartOf":{"@id":"https:\/\/livingstonepartners.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#primaryimage"},"image":{"@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#primaryimage"},"thumbnailUrl":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png","datePublished":"2023-04-24T04:00:00+00:00","dateModified":"2026-06-25T14:09:19+00:00","breadcrumb":{"@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#primaryimage","url":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png","contentUrl":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png","width":550,"height":370},{"@type":"BreadcrumbList","@id":"https:\/\/livingstonepartners.com\/es\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/livingstonepartners.com\/es\/"},{"@type":"ListItem","position":2,"name":"Transactions","item":"https:\/\/livingstonepartners.com\/es\/transaction\/"},{"@type":"ListItem","position":3,"name":"Livingstone asesora a neoplas med en su ronda de financiaci\u00f3n de serie B"}]},{"@type":"WebSite","@id":"https:\/\/livingstonepartners.com\/es\/#website","url":"https:\/\/livingstonepartners.com\/es\/","name":"Livingstone Partners","description":"Deals Done Right.","publisher":{"@id":"https:\/\/livingstonepartners.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/livingstonepartners.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/livingstonepartners.com\/es\/#organization","name":"Livingstone Partners","url":"https:\/\/livingstonepartners.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/livingstonepartners.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/logo_livingstone.svg","contentUrl":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/logo_livingstone.svg","caption":"Livingstone Partners"},"image":{"@id":"https:\/\/livingstonepartners.com\/es\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/16365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction"}],"about":[{"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/types\/transaction"}],"version-history":[{"count":1,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/16365\/revisions"}],"predecessor-version":[{"id":70077,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/16365\/revisions\/70077"}],"acf:post":[{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/15963"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/16055"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/16187"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction\/16346"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/team-member\/1801"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/team-member\/1773"}],"acf:term":[{"embeddable":true,"taxonomy":"sector","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/sector\/852"},{"embeddable":true,"taxonomy":"sector","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/sector\/843"},{"embeddable":true,"taxonomy":"region","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/region\/1219"},{"embeddable":true,"taxonomy":"region","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/region\/402"},{"embeddable":true,"taxonomy":"region","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/region\/396"},{"embeddable":true,"taxonomy":"transaction-type","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction-type\/1034"},{"embeddable":true,"taxonomy":"client-type","href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/client-type\/46"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/media\/3863"}],"wp:attachment":[{"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/media?parent=16365"}],"wp:term":[{"taxonomy":"client-type","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/client-type?post=16365"},{"taxonomy":"region","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/region?post=16365"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/sector?post=16365"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/service?post=16365"},{"taxonomy":"transaction-type","embeddable":true,"href":"https:\/\/livingstonepartners.com\/es\/wp-json\/wp\/v2\/transaction-type?post=16365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}